IOBT
IO Biotech, Inc.
Key Financials
Operating Income
$-95177000
↓ 4.1%
Net Income
$-95491000
↓ 10.9%
EPS (Diluted)
$-1.45
↑ 26.8%
Cash & Equivalents
$60.0M
↓ 58.1%
Total Liabilities
$20.7M
↑ 17.8%
Total Assets
$67.7M
↓ 55.1%
Shareholders' Equity
$47.0M
↓ 64.7%
Long-term Debt
$0.00
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IOBT |
| Company Name | IO Biotech, Inc. |
| CIK | 1865494 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 4570702980 |